ImmunoVec
About:
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.
Website: https://www.immunovec.com/
Description:
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system. Its gene therapy is intended for hematopoietic diseases.
Total Funding Amount:
$4.3M
Headquarters Location:
Santa Monica, California, United States
Founded Date:
2019-01-01
Founders:
Katelyn Masiuk, Ryan Wong, William Woodward
Number of Employees:
1-10
Last Funding Date:
2022-03-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai